Nuveen Asset Management’s Tourmaline Bio TRML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.55M | Buy |
76,245
+13,504
| +22% | +$274K | ﹤0.01% | 2493 |
|
|
2024
Q3 | $1.61M | Sell |
62,741
-17,104
| -21% | -$440K | ﹤0.01% | 2523 |
|
|
2024
Q2 | $1.03M | Buy |
+79,845
| New | +$1.03M | ﹤0.01% | 2720 |
|
|
2022
Q3 | – | Sell |
-6,152
| Closed | -$277K | – | 3211 |
|
|
2022
Q2 | $277K | Buy |
6,152
+2,000
| +48% | +$90.1K | ﹤0.01% | 3111 |
|
|
2022
Q1 | $340K | Hold |
4,152
| – | – | ﹤0.01% | 3099 |
|
|
2021
Q4 | $589K | Buy |
4,152
+1,827
| +79% | +$259K | ﹤0.01% | 3029 |
|
|
2021
Q3 | $328K | Buy |
2,325
+915
| +65% | +$129K | ﹤0.01% | 3238 |
|
|
2021
Q2 | $207K | Buy |
+1,410
| New | +$207K | ﹤0.01% | 3245 |
|